The European Commission Just Approved MVASI, One of The First Biosimilar Cancer Drugs
source: pixabay.com

The European Commission Just Approved MVASI, One of The First Biosimilar Cancer Drugs

According to an article from PRNewswire, the drug MVASI (biosimilar bevacizumab) was just granted marketing authorization by the European Commission. Developed by Amgen and Allergan, this treatment has been approved…

Continue Reading The European Commission Just Approved MVASI, One of The First Biosimilar Cancer Drugs
Extreme Athlete Anthony Anzell Doesn’t Let His Hereditary Hemmorhagic Telangiectasia Slow Him Down
Source: Pixabay

Extreme Athlete Anthony Anzell Doesn’t Let His Hereditary Hemmorhagic Telangiectasia Slow Him Down

Reported by Fox 2, Anthony Anzell doesn’t let his rare genetic disease hold him back. Anthony is an extreme athlete who just swam 19 miles, the entire length of Torch…

Continue Reading Extreme Athlete Anthony Anzell Doesn’t Let His Hereditary Hemmorhagic Telangiectasia Slow Him Down
Braving the Storm: How Music and Family Helped Tara Get Through a Tough, Rare, Little-Known Disease
Source: Pixabay

Braving the Storm: How Music and Family Helped Tara Get Through a Tough, Rare, Little-Known Disease

I know you’re fighting hard//I see your battle scars     It’s clear you’ve come so far//You’ll grow stronger Alone, these words may feel like just expressions of encouragement; a…

Continue Reading Braving the Storm: How Music and Family Helped Tara Get Through a Tough, Rare, Little-Known Disease
Anti-Psychotic Drug Could Prolong The Lives of Amyotrophic Lateral Sclerosis Patients
Pexels / Pixabay

Anti-Psychotic Drug Could Prolong The Lives of Amyotrophic Lateral Sclerosis Patients

According an article from CityNews Toronto, an anti-psychotic medication is undergoing clinical trials in the treating of amyotrophic lateral sclerosis. In other studies, the treatment has shown to help slow…

Continue Reading Anti-Psychotic Drug Could Prolong The Lives of Amyotrophic Lateral Sclerosis Patients